Silverback Therapeutics is based in Seattle, WA. It has raised $210M in total funding. Latest round: Series C.
Silverback Therapeutics is based in Seattle, WA. Silverback Therapeutics has raised $210M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in September 2020. The round record for Silverback Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include EcoR1 Capital, RA Capital, OrbiMed Advisors, U.S. Venture Partners, Boxer Capital, Fidelity Management & Research Company LLC and 4 others. 10 distinct backers are named across the disclosed rounds.
Totals shown for Silverback Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Seattle and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026